A Study of OV101 in Individuals With Angelman Syndrome (AS)
Trial details
- Registry ID
- NCT04106557
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of OV101 in Individuals With Angelman Syndrome (AS)NCT04106557 | OVID | Phase 3 | Completed | 2020-11-02Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |